NICE Launches CXone Mpower SmartSpeak, Eliminating Language Barriers in Real-Time for Exceptional Global CX
Redfin Survey: 38% of People Who Already Voted Say Housing Affordability Impacted Their Presidential Pick
HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200604, a Best-in-Class BTLA Agonist Antibody for the Treatment of Inflammatory and Immunology Diseases